Rezo is excited to be included among @biospace's NextGen Class of 2024! 2023 was an important year for Rezo and we look forward to carrying that same momentum into the new year as we seek to unlock a new era of #drugdiscovery. https://t.co/W5cyjpbXAx
Bright Minds: Mapping autism spectrum disorder protein interactions with the director of @QBI_UCSF. A science conversation that expands on work posed to BioRxiv this morning.
Full video: https://t.co/24vhEUFapS
New preprint alert! We mapped a foundational protein-protein interaction (PPI) network involving 100 high-confidence (hc) autism spectrum disorder (ASD) risk genes, and leveraged AlphaFold2 to reveal a deeper mechanistic understanding of autism biology🧵👇https://t.co/cdIC8cGmmF
@MichelleAkerst1@michelletandler Wow, I’m surprised you felt the need to respond like that. The school has a wonderful, caring staff and community that work hard every day with the resources they have to serve the needs of the students, giving them a well rounded education. I wish you would have supported them.
@MichelleAkerst1@frank_smith1111 Wow, I’m surprised you felt the need to respond like that. The school has a wonderful, caring staff and community that work hard every day with the resources they have to serve the needs of the students, giving them a well rounded education. I wish you would have supported them.
George Scangos, biotech veteran, led a panel discussion with Hal Barron, CEO of @altos_labs & @CatherineRLucey, Executive Vice Chancellor & Provost @UCSF. They explored innovative pathways for bridging basic research & drug development, with Altos Labs as a powerful case study.
Ron Leuty @SFBusinessTimes, led a thought-provoking panel discussion with @vintweeta of @a16z, QBI Director @KroganLab, and George Scangos, biotech veteran. Together, they explored transformative perspectives on reshaping the narrative around the academia-to-industry transition.
We’re happy to celebrate the first ever Discovery | Innovation | Health Prize recipient, Dr. Nevan Krogan for his trailblazing efforts to address #pandemic threats. He is being honored now at #RAForum. #DIHprize@QBI_UCSF@KroganLab@pfizer https://t.co/6CWNb509IP
We’re excited to announce Dr. Nevan Krogan as the Discovery | Innovation | Health Prize recipient for his trailblazing efforts to address pandemic threats. He will be honored today at #RAForum. #DIHprize@QBI_UCSF@KroganLab@Pfizer https://t.co/6CWNb509IP
Thank you Max Bayer and @FierceBiotech for the great piece highlighting the addition of Nadir Mahmood, Ph.D., as our CEO. Hear what he and Rezo co-founder and president Nevan Krogan, Ph.D., had to say about the future of our approach here: https://t.co/JaJuDszXrx
We're excited to welcome Nadir Mahmood, Ph.D., as CEO and board member! His expertise will play a pivotal role as we seek to shift the way we understand disease biology through our integrated mapping of disease networks for precision therapeutics. https://t.co/NwrdYyLNIs
QBI Director Nevan Krogan receives the first-ever $200,000 Discovery | Innovation | Health Prize from
@ResearchAmerica for his trailblazing efforts to address future pandemic threats, at the National Health Research Forum in DC. https://t.co/mZca4kzZud